-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – ciraparantag acetate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ciraparantag acetate Drug Details Ciraparantag acetate (PER-977,Aripazine) is under development as an antidote for...
-
Product Insights
![]()
Hypoglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hypoglycemia is a condition characterized by an abnormally low level of blood sugar (glucose). Symptoms of hypoglycemia include tachycardia, anxiety, shaking, irritability, feelings of hunger, weakness, tiredness, dizziness, headache, confusion, and trouble concentrating. Risk factors include drug or alcohol consumption, older age, longer duration of diabetes, renal disease, peripheral neuropathy, obesity, and cognitive dysfunction. The Hypoglycemia drugs in development market research report provide comprehensive information on the therapeutics under development for Hypoglycemia, complete with analysis by stage of development, drug...
-
Product Insights
![]()
Traumatic Brain Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping, and memory or concentration problems. Risk factor includes age. Certain types of traumatic brain injury increase the risk of developing Alzheimer's disease and coordination problems. The traumatic brain injury drugs in development market research report provides an overview...
-
Product Insights
![]()
Raynauds Disease – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report provides data on the Raynaud disease clinical trial scenario. This report provides top-line data relating to the clinical trials on Raynaud Disease. The report includes an overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based...
-
Product Insights
![]()
Pre-Eclampsia – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Pre-Eclampsia - Global Clinical Trials Review, H2, 2021" provides an overview of Pre-Eclampsia Clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Eclampsia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for...
-
Product Insights
![]()
Raynauds Disease – Global Clinical Trials Review, H1, 2021
GlobalData's clinical trial report, “Raynauds Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Raynauds Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Raynauds Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
-
Product Insights
![]()
Raynauds Disease Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, H2, 2020" provides an overview of Raynauds Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Raynauds Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
![]()
Raynauds Disease Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, H1, 2020" provides an overview of Raynauds Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Raynauds Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
![]()
Raynauds Disease Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, H1, 2018" provides an overview of Raynauds Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Raynauds Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
![]()
Raynauds Disease Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, H1, 2016" provides an overview of Raynauds Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Raynauds Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.